Bon Natural Life (BON) Competitors $1.41 -0.05 (-3.42%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.40 0.00 (-0.35%) As of 07/18/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BON vs. TRVN, PTPI, SYRS, SRNE, BIOR, HEPA, BPTSY, VRPX, VIRX, and TFFPShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include Trevena (TRVN), Petros Pharmaceuticals (PTPI), Syros Pharmaceuticals (SYRS), Sorrento Therapeutics (SRNE), Biora Therapeutics (BIOR), Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Viracta Therapeutics (VIRX), and TFF Pharmaceuticals (TFFP). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. Its Competitors Trevena Petros Pharmaceuticals Syros Pharmaceuticals Sorrento Therapeutics Biora Therapeutics Hepion Pharmaceuticals Biophytis Virpax Pharmaceuticals Viracta Therapeutics TFF Pharmaceuticals Trevena (NASDAQ:TRVN) and Bon Natural Life (NYSE:BON) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings. Does the media favor TRVN or BON? In the previous week, Bon Natural Life had 1 more articles in the media than Trevena. MarketBeat recorded 1 mentions for Bon Natural Life and 0 mentions for Trevena. Trevena's average media sentiment score of 0.00 equaled Bon Natural Life'saverage media sentiment score. Company Overall Sentiment Trevena Neutral Bon Natural Life Neutral Do analysts recommend TRVN or BON? Trevena presently has a consensus price target of $5.00, suggesting a potential upside of 449.45%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than Bon Natural Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Bon Natural Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation and earnings, TRVN or BON? Bon Natural Life has higher revenue and earnings than Trevena. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrevena$443K1.97-$40.29M-$47.04-0.02Bon Natural Life$23.84M0.01$400KN/AN/A Is TRVN or BON more profitable? Company Net Margins Return on Equity Return on Assets TrevenaN/A N/A -119.55% Bon Natural Life N/A N/A N/A Do insiders and institutionals have more ownership in TRVN or BON? 13.6% of Trevena shares are held by institutional investors. Comparatively, 0.6% of Bon Natural Life shares are held by institutional investors. 2.7% of Trevena shares are held by insiders. Comparatively, 26.5% of Bon Natural Life shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, TRVN or BON? Trevena has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Bon Natural Life has a beta of -0.49, meaning that its share price is 149% less volatile than the S&P 500. SummaryTrevena and Bon Natural Life tied by winning 5 of the 10 factors compared between the two stocks. Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeMedicinals & botanicals IndustryDiscretionary SectorNYSE ExchangeMarket Cap$235K$3.44B$8.39B$20.84BDividend YieldN/AN/A3.19%3.65%P/E RatioN/A7.6220.8627.56Price / Sales0.0126.383.3258.99Price / Cash0.785.6216.6222.29Price / Book0.041.104.814.66Net Income$400K$17.44M$215.29M$994.58M7 Day Performance-4.73%-12.86%5.39%-0.29%1 Month Performance2.92%-6.41%38.62%4.90%1 Year Performance-97.29%-37.62%14.96%11.14% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural LifeN/A$1.41-3.4%N/A-97.4%$235K$23.84M0.00100Gap DownTRVNTrevena1.24 of 5 stars$0.91-2.4%$5.00+448.0%-85.2%$875K$443K-0.0240Positive NewsGap DownHigh Trading VolumePTPIPetros PharmaceuticalsN/A$0.03-3.5%N/A-99.7%$857K$5.11M-0.0120SYRSSyros Pharmaceuticals4.1406 of 5 stars$0.03+197.0%$3.33+11,011.1%-99.8%$805K$386K-0.01120SRNESorrento Therapeutics0.5813 of 5 stars$0.00-45.8%N/A-84.4%$717K$60.32M0.00800High Trading VolumeBIORBiora Therapeutics1.8032 of 5 stars$0.15+6.5%$23.00+15,664.2%-97.9%$660K$892K-0.01120Gap UpHEPAHepion Pharmaceuticals0.1377 of 5 stars$0.06-6.2%N/A-99.9%$615KN/A-0.0120Gap UpBPTSYBiophytisN/A$1.33-8.3%N/A-71.3%$467KN/A0.0030Gap DownVRPXVirpax PharmaceuticalsN/A$0.37+4.7%$75.00+20,164.8%-98.8%$460KN/A0.007VIRXViracta Therapeutics2.0262 of 5 stars$0.01-8.2%$1.75+17,226.7%N/A$401KN/A-0.0120TFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289K$730K-0.0119 Related Companies and Tools Related Companies Trevena Competitors Petros Pharmaceuticals Competitors Syros Pharmaceuticals Competitors Sorrento Therapeutics Competitors Biora Therapeutics Competitors Hepion Pharmaceuticals Competitors Biophytis Competitors Virpax Pharmaceuticals Competitors Viracta Therapeutics Competitors TFF Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BON) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BON Stock Alerts